SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
LumiraDx Limited (LMDX) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+9275%).
- Analyst consensus target $1.50 (+9275% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 44/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LMDX
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.02
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.59
Book Value / Share$0.00
Revenue / Share$0.90
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$1.50 (+9275%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.53 |
$23.14M |
$-133.11M |
-575.2% |
| 2020 |
$-0.95 |
$139.15M |
$-241M |
-173.2% |
| 2021 |
$-0.62 |
$421.43M |
$-100.76M |
-23.9% |
| 2022 |
$-1.59 |
$254.48M |
$-449.2M |
-176.5% |
